After selecting the Centers carrying out the clinical trial, i.e. the Bielański Hospital and the University Clinical Center of the Medical University of Warsaw, and after many months of work related to obtaining permission from the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products to conduct a clinical trial, an official meeting of the Partners implementing the FootCell project took place. It was also attended by representatives of the Scientia Research Institute, which acts as the CRO in this study. All Partners provided the remaining participants with the most important information focusing on the current course of the clinical trial, the state of progress in patient recruitment and the production of medicinal products at the LBBK.